NEJM Oct 2020. DOI:10.1056/NEJMoa2007764 Beigel J.H, Tomashek K.M., Dodd A.K et al.
Remdesivir for the Treatment of Covid-19: Final Report
Coronary Angiography after Cardiac Arrest without ST-Segment Elevation (COACT)
Lemkes JS, Janssens GN, van der Hoeven NW et al. New England Journal of Medicine 2019. DOI: 10.1056/NEJMoa1816897
Anaesthetic depth and complications after major surgery: an international, randomised controlled trial
Short TG, Campbell D, Frampton C et al.
The Lancet 2019 394: 1907-1914. https://doi.org/10.1016/S0140-6736(19)32315-3
Early Use of Noradrenaline in Septic Shock Resuscitation (CENSER): A Randomized Trial
Permpikul C, Tongyoo S, Viarasilpa T et al.
American Journal of Respiratory and Critical Care Medicine 2019, 199, 9:1097-1105. doi: 10.1164/rccm.201806-1034OC.
Effects of Tranexamic Acid on Death, Disability, Vascular Occlusive Events and Other Morbidities in Patients with Acute Traumatic Brain Injury (CRASH-3): a Randomised, Placebo-Controlled Trial
CRASH-3 collaborators
The Lancet 2019: October 14. DOI:https://doi.org/10.1016/S0140-6736(19)32233-0
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
Villanueva C, Colomo A, Bosch A Iet al.
The New England Journal of Medicine 2013; 368:11-21
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock (APPROCCHSS trial)
Annane D, Renault A, Brun-Buisson C et al.
New England Journal of Medicine 2018; 378: 809-818
Early Sedation with Dexmedetomidine in Critically Ill Patients – part of ANZICS Clinical Trial Group and SPICE III Study (Sedation Practice in Intensive Care Evaluation)
Shehabi Y, Howe BD, Bellomo R et al.
New England Journal of Medicine . 19 May 2019 DOI: 10.1056/NEJMoa1904710
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest
Perkins G.D., Ji C., Deakin C.D. et al.
The New England Journal of Medicine 2018; 379(8): 711-21.. DOI: 10.1056/NEJMoa1806842
Sodium Bicarbonate Therapy for Patients with Severe Metabolic Acidaemia in the Intensive Care Unit (BICAR-ICU); a Multicentre, Open-label Randomised Controlled Phase 3 Trial
Jaber S; Paugam C, Futier E et al.
The Lancet 2019, 393, P31-40
